Program
Friday, August 15th |
|||
| 8:00-8:30 am | R. Andrew Byrd, Ph.D., Director, Molecular Discovery Program, CCR Welcoming Remarks |
||
| 8:30-9:00 am | Gregory L. Verdine, Ph.D., Harvard University Cancer Chemical Biology |
||
| 9:00-9:30 am | Carolyn Bertozzi, Ph.D., University of California, Berkeley Imaging the Glycome |
||
| 9:30-10:00 am | Benjamin F. Cravatt III, Ph.D., Skaggs Institute/Chemical Biology, Scripps Mapping Pathways in Human Disease by Activity-Based Proteomics & Metabolomics |
||
| 10:00-10:30 am | Coffee Break | ||
| 10:30-11:00 am | Jon Clardy, Ph.D., Harvard Medical School Ecological insights into Small Molecule Discovery, Biosynthesis, and Evolution |
||
| 11:00-11:30 am | Peter Schultz, Ph.D., Scripps Research Institute Synthesis at the Interface of Chemistry and Biology |
||
| 11:30-12:00 pm | Craig Thomas, Ph.D., Chemical Genomics Center, NIH Integrating Chemistry with Biology at the NIH: Big Challenges and Bigger Opportunities |
||
| 12:00-1:30 pm | Poster Session with Refreshments | ||
| 1:30-2:00 pm | Angela Belcher, Ph.D., Massachusetts Institute of Technology From Nature & Back Again: Giving New life to Materials for Energy, Environment & Medicine |
||
| 2:00-2:30 pm | James R. Heath, Ph.D., California Institute of Technology Systems Biology-Driven Technologies for In Vitro Diagnosis & Analysis of Cancer |
||
| 2:30-3:00 pm | Laura L. Kiessling, Ph.D., University of Wisconsin-Madison Low-Affinity Interactions for High-Specificity Tumor Cell Targeting |
||
| 3:00-3:30 pm | Coffee Break | ||
| 3:30-4:00 pm | Lawrence Marnett, Ph.D., Vanderbilt Institute of Chemical Biology Targeting Cyclooxygenase-2 for Cancer Imaging and Therapeutics |
||
| 4:00-4:30 pm | Milan Mrksich, Ph.D., University of Chicago BioChips Without the Labels: Applications to Histone Modification |
||
| 4:30-5:00 pm | Amy Jacobs, Ph.D., CCR Nanobiology Program Probing Conformational Changes in Membrane Proteins During Membrane Fusion |
||
| 5:00-7:00 pm | Poster Session with Refreshments | ||
Saturday, August 16th |
|||
| 8:30-9:00 am | Alanna Schepartz, Ph.D., Yale University Imaging Protein Assembly and Trafficking in Live Cells Without Fluorescent Proteins |
||
| 9:00-9:30 am | Mike E. Jung, Ph.D., University of California, Los Angeles Rational Drug Design for the Treatment of Hormone-Refractory Prostate Cancer |
||
| 9:30-10:00 am | Cynthia J. Burrows, Ph.D., University of Utah Chemistry and Biology of Oxidative DNA Damage |
||
| 10:00-10:30 am | Coffee Break | ||
| 10:30-11:00 am | Elio Abbondanzieri, Ph.D., Harvard University Molecular Gymnastics: Dynamic Binding Orientations of HIV Reverse Transcriptase |
||
| 11:00-11:30 am | Moungi G. Bawendi, Ph.D., Massachusetts Institute of Technology Designing Quantum Dots for Biological and Biomedical Imaging |
||
| 11:30-12:00 pm | Yves Pommier, Ph.D., Chief, Laboratory of Molecular Pharmacology, CCR Non-Camptothecin Topoisomerase I Inhibitors: a 10 Year Odyssey |
||
